Gillette Stadium partners with Tomorrow.io to operate at maximum efficiency throughout storms to prevent wasted vaccines.
BOSTON, Mass., March 4, 2021 – Gillette Stadium is helping the Commonwealth of Massachusetts get back to normal in a big way, by opening the stadium as a COVID-19 mass-vaccination site. With roughly 6.8 million residents in the state, venues for mass vaccinations are critical to administering the COVID-19 vaccine to the state’s population as quickly as possible and Gillette Stadium’s operation is the largest provider in the state.
In addition to the general challenges of distributing thousands of vaccines per day, including scheduling, administration, recording, distributing, traffic, parking lot management, and more, unexpected weather can negatively impact operations. Snowstorms and additional weather parameters can wreak havoc on vaccine operations at scale if not planned for in advance. For instance, during a storm, people need to reschedule their vaccination appointments, vaccines need to be stored properly to ensure they are not being wasted, and both workers and on-site stadium customers need to be kept safe from hazardous weather conditions.
“Our goal here at Gillette Stadium is to get as many people safely vaccinated as quickly as possible. We all want a return to normalcy as soon as possible and this is how we can help the Commonwealth, along with our incredible doctors, nurses, and frontline employees,” said Jason Stone, VP of Operations at Gillette Stadium. “Weather plays a significant role in our ability to safely and efficiently get people vaccinated, and by partnering with Tomorrow.io, we’re able not only to know when inclement weather is on the way, but more importantly, how it will impact our operations so we can make operational changes in advance, ensuring we reduce any impact to the vaccination efforts.”
Tomorrow.io, headquartered in Boston, is the world’s leading Weather Intelligence Platform. With customers including Uber, Ford, National Grid, JetBlue, ITS ConGlobal, and more, the company is disrupting the weather industry by offering technology that predicts the operational impact of incoming weather and automates the processes that need to happen before it’s too late.
“What the Kraft Group is doing to help the Commonwealth of Massachusetts move forward is tremendous, and I can’t thank them enough in addition to all of the doctors, nurses, and frontline employees,” said Dan Slagen, CMO of Tomorrow.io. “We’ve already seen a number of instances across the country where weather has unexpectedly shut down a vaccination site, wasting time, vaccinations, and put people at safety risks, which is why we are working hand in hand with Gillette Stadium officials to help in them in their heroic efforts to distribute mass vaccinations at unprecedented levels of scale.”
With Tomorrow.io, Gillette Stadium is able to look at a dashboard on a computer or mobile phone for the coming week and see when their vaccination operations will be impacted by the weather and how. The dashboard doesn’t display traditional weather updates such as “snow on Tuesday at 10 AM” but rather focuses on impact by displaying “Update vaccination hours Tuesday from 10 AM – 1 PM, send updates to appointments that will be canceled for rescheduling, and update vaccine usage needs for the day.” The focus is on impact, team communication, and operational efficiency so that the team at Kraft Group can focus on distributing vaccines as opposed to trying to understand how the weather forecast will impact their operations on the fly.
About Tomorrow.io:
Tomorrow.io is the world’s leading All-in-One Weather Intelligence Platform™. Fully customizable to any industry impacted by the weather, customers around the world including Uber, Delta, Ford, National Grid, and more use Tomorrow.io to dramatically improve operational efficiency. Tomorrow.io was built from the ground up to help teams predict the business impact of weather, streamline team communication and action plans, improve productivity, and optimize profit margins.
Media Contact:
